Know Cancer

or
forgot password
  • cancer clinical trials in washington

  • Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer
    The George Washington University
    Washington, District of Columbia 20037
    Breast Cancer
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Children's National Medical Center
    Washington, District of Columbia 20010-2970
    Brain Tumor, Central Nervous System Tumor
    PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen
    Lombardi Comprehensive Cancer Center

    Trial Locations
    Lombardi Comprehensive Cancer Center
    Washington Hospital Cancer Center
    Pancreatic Cancer
    Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Washington, District of Columbia 20007
    Breast Cancer
    Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
    Washington Cancer Institute at Washington Hospital Center
    Washington, District of Columbia 20010
    Melanoma (Skin)
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Washington Hospital Center

    Trial Locations
    Washington Hospital Center
    Lombardi Comprehensive Cancer Center at Georgetown University
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Howard University Cancer Center at Howard University Hospital
    Washington, District of Columbia 20060
    Colorectal Cancer
    Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Washington, District of Columbia 20007
    Colorectal Cancer, Metastatic Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Washington Cancer Institute at Washington Hospital Center
    Washington, District of Columbia 20010
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Walter Reed Army Medical Center

    Trial Locations
    Walter Reed Army Medical Center
    Children's National Medical Center
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Washington Hospital Center
    Washington, District of Columbia 20010
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Walter Reed Army Medical Center
    Washington, District of Columbia 20307-5000
    Multiple Myeloma and Plasma Cell Neoplasm
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Sibley Memorial Hospital
    Washington, District of Columbia 20016
    Breast Cancer
    Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Washington, District of Columbia 20007
    Lymphoma
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Washington Cancer Institute at Washington Hospital Center

    Trial Locations
    Washington Cancer Institute at Washington Hospital Center
    Georgetown University Med Ctr
    Myeloid Leukemia, Chronic, Chronic-Phase
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Lombardi Comprehensive Cancer Center at Georgetown University
    Washington, District of Columbia 20057
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    Children's National Medical Center

    Trial Locations
    Children's National Medical Center
    Lombardi Comprehensive Cancer Center at Georgetown University
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Washington, District of Columbia 20007
    Metastatic Cancer, Prostate Cancer
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Washington Cancer Institute
    Washington, District of Columbia 20010
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Walter Reed Army Medical Center

    Trial Locations
    Walter Reed Army Medical Center
    Georgetown University Medical Center
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Sibley Memorial Hospital
    Washington, District of Columbia 20016
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cetuximab With or Without Carboplatin in Treating Women With Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
    Washington Cancer Institute at Washington Hospital Center

    Trial Locations
    Washington Cancer Institute at Washington Hospital Center
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Breast Cancer
    Radiation Therapy in Treating Young Patients With Gliomas
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Washington, District of Columbia 20007
    Brain Tumor, Central Nervous System Tumor
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Lombardi Comprehensive Cancer Center at Georgetown University
    Washington, District of Columbia 20057
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
    GSK Clinical Trials Call Center
    Washington, District of Columbia 20307-5001
    Non-Hodgkin's Lymphoma
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Washington Onc Hem Center PC
    Washington, District of Columbia 20037
    Non-Small Cell Lung Cancer
    Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
    Pfizer Investigational Site
    Washington, District of Columbia 20007-2197
    Chronic Myeloid Leukemia
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Washington Hospital Center
    Washington, District of Columbia 20010
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Washington Hospital Center
    Washington, District of Columbia 20010
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
    GSK Investigational Site
    Washington, District of Columbia 20307-5001
    Neoplasms, Breast
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Washington Cancer Institute at Washington Hospital Center

    Trial Locations
    Washington Cancer Institute at Washington Hospital Center
    Sibley Memorial Hospital
    Colorectal Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Children's National Medical Center

    Trial Locations
    Children's National Medical Center
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Leukemia
    Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
    Gynecologic Disease Center, Walter Reed Army Medical Center
    Washington, District of Columbia 20307
    Endometrial Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Leiomyoma
    Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer
    Georgetown University Medical Center / Lombardi Cancer Center
    Washington, District of Columbia 20007
    Pancreas Cancer
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    Children's National Medical Center
    Washington, District of Columbia 20010-2970
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Washington Cancer Institute at Washington Hospital Center
    Washington, District of Columbia 20010
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    George Washington University Medical Center

    Trial Locations
    George Washington University Medical Center
    Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Washington Hospital Center

    Trial Locations
    Washington Hospital Center
    Lombardi Comprehensive Cancer Center at Georgetown University
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    Washington Hospital Center

    Trial Locations
    Washington Hospital Center
    Georgetown University/Lombardi Cancer Center
    Breast Cancer